No Image

New study offers hope for patients suffering from a rare form of blindness

November 11, 2018 dna 0
A new form of therapy may halt or even reverse a form of progressive vision loss that, until now, has inevitably led to blindness. This hyper-targeted approach offers hope to individuals living with spinocerebellar ataxia type 7 (SCA7) and validates a new form of therapy with the potential to treat neurogenetic diseases effectively and with far fewer side effects than other medications.
No Image

Studies highlight lasting effects of early life stress on the genome, gut, and brain

November 11, 2018 dna 0
Excessive stress during fetal development or early childhood can have long-term consequences for the brain, from increasing the likelihood of brain disorders and affecting an individual’s response to stress as an adult to changing the nutrients a mother may pass on to her babies in the womb. The new research suggests novel approaches to combat the effects of such stress, such as inhibiting stress hormone production or ‘resetting’ populations of immune cells in the brain.
No Image

Realizing the potential of gene therapy for neurological disorders

November 11, 2018 dna 0
Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders. Scientists have successfully used gene therapy to slow the progression and improve symptoms of disorders such as amyotrophic lateral sclerosis and Parkinson’s disease.